Screening for second malignancies in mycosis
Screening for second malignancies in mycosis fungoides: Non-Hodgkin lymphoma, Hodgkin lymphoma, lung most cancers, bladder most cancers, and melanoma
Background: Sufferers with mycosis fungoides (MF) are at elevated danger of growing non-Hodgkin lymphoma (NHL),Hodgkin lymphoma (HL), lung most cancers, bladder most cancers, and melanoma. There are not any pointers for screening MF sufferers for second malignancies.
Supplies/strategies: We recognized 742 sufferers with MF and second malignancies within the Surveillance Epidemiology and Finish Outcome-18 database.
Outcomes: The vast majority of second malignancy sufferers had been white and male, imply ages 55-67 years at prognosis of MF, and imply age of 61-72 years at prognosis of second malignancy. MF/NHL, MF/lung most cancers, and MF/bladder, most cancers tended to be identified at earlier phases of the second malignancy than sufferers with NHL, lung most cancers, or bladder cancers alone and have improved survival. There was no enchancment in stage at prognosis or survival for MF/melanoma sufferers.
Conclusions: Enhancements in survival in MF/NHL, MF/lung most cancers, and MF/bladder most cancers sufferers might replicate underlying biology or the significance of elevated contact with the healthcare system. MF/melanoma knowledge means that sufferers require pigmented-lesion centered pores and skin exams. Instruments for screening embody common lymph node exams, pigmented-lesion centered exams, and detailed assessment of methods questions. With these easy interventions, we hope to establish second malignancies sooner and doubtlessly keep away from them.
) EF1a Control lentiviral particles (Neo) |
|||
| EF1a-Null-Neo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. |
|||
) EF1a Control lentiviral particles (Puro) |
|||
| EF1a-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
) EF1a Control lentiviral particles (GFP-Bsd) |
|||
| EF1a-Null-GB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. |
|||
) EF1a Control lentiviral particles (GFP-Puro) |
|||
| EF1a-Null-GP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. |
|||
) EF1a Control lentiviral particles (RFP-Bsd) |
|||
| EF1a-Null-RB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. |
|||
) EF1a Control lentiviral particles (RFP-Puro) |
|||
| EF1a-Null-RP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. |
|||
) EF1a control lentivirus (Hygro) |
|||
| EF1a-Null-Hygro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter. |
|||
) EF1a control lentivirus (Zeo) |
|||
| EF1a-Null-Zeo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter. |
|||
 in PBS) EF1a Control lentiviral particles (Bsd) in PBS |
|||
| EF1a-Null-Bsd-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (Neo) in PBS |
|||
| EF1a-Null-Neo-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (Puro) in PBS |
|||
| EF1a-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (GFP-Bsd) in PBS |
|||
| EF1a-Null-GB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (GFP-Puro) in PBS |
|||
| EF1a-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (RFP-Bsd) in PBS |
|||
| EF1a-Null-RB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (RFP-Puro) in PBS |
|||
| EF1a-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 (EF1a) (pLenti-GIII-EF1a)) DPY19L1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723334 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DRD5P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723358 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DRD5P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723364 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DSTNP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723388 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DSTNP3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723394 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DTX2P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723400 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DURS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723406 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUSPP Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723412 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723418 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723424 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723430 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723436 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723442 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723448 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUTP8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723454 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723460 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723466 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L11 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723472 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L14 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723478 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723484 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723490 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L18 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723496 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUX4L19 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723502 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DUXB Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723508 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DVL1L1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723514 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DWS Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723520 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYNLL1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723526 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYRK1AIP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723532 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYRK1AIP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723538 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723544 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723550 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723556 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723562 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT13 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723568 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723574 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723580 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT21 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723586 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYT22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723592 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723598 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723610 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723616 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723622 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723628 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723634 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723640 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723646 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) DYX9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723652 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) E2F3P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723664 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) E2F4P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723670 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) E11S Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723676 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EBM Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723688 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EBR3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723694 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EBR4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723700 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EBVM1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723706 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EBVS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723712 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) ECA1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723718 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) ECEL1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723724 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) ECEL1P3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723730 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EDDM3DP Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723736 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723742 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEC2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723748 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723754 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723760 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723766 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723772 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723778 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P18 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723784 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723790 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P23 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723796 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P25 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723802 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P26 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723808 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P28 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723814 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P29 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723820 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P30 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723826 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P31 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723832 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P33 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723838 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P34 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723844 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P35 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723850 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P38 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723856 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P40 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723862 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A1P41 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723868 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1A3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723874 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1B2P5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723880 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EEF1DP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723886 | ABM | 1.0 ug DNA | Ask for price |
Histopathological options and outcomes of DUSP22 Rearrangement in Main Cutaneous Anaplastic Massive Cell Lymphoma: a case report and assessment of the literature
cell markers, with unique cutaneous onset and localization1 . Good prognosis and response to remedy characterised C-ALCL with a ten-year-disease-free survival of ~90% very totally different from that of the systemic types of ALCL (S-ALCL)2 . S-ALCL are categorised as ALK (anaplastic lymphoma kinase) constructive (+) or ALK unfavourable (-)2 .
Non-Hodgkin Lymphoma Metabolism
Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with totally different organic traits. About 90% of all lymphomas in the US originate from B lymphocytes, whereas the remaining originate from T cells [1]. The remedy of NHLs will depend on the neoplastic histology and stage of the tumor, which can point out whether or not radiotherapy, chemotherapy, or a mix is the very best appropriate remedy [2]. The American Most cancers Society describes the staging of lymphoma as follows: Stage I is lymphoma in a single node or space.
Stage II is when that lymphoma has unfold to a different node or organ tissue. Stage III is when it has unfold to lymph nodes on two sides of the diaphragm. Stage IV is when most cancers has considerably unfold to organs exterior the lymph system. Radiation remedy is the normal therapeutic route for localized follicular and mucosa-associated lymphomas. Chemotherapy is utilized for the remedy of large-cell lymphomas and high-grade lymphomas [2]. Nevertheless, the remedy of indolent lymphomas stays problematic because the sufferers usually have metastasis, for which no normal strategy exists [2].
Main intramedullary spinal-cord lymphoma (PISCL): a uncommon entity with a difficult prognosis
Main intramedullary spinal-cord lymphoma (PISCL) is a uncommon explanation for myelopathy and constitutes just one% of central nervous system lymphomas. Delay to prognosis is widespread as a result of its rarity, its similarity to different causes of myelopathy and the difficulties in acquiring pathological prognosis. We report a case of PISCL and focus on the challenges confronted on prognosis, particularly the influence of corticosteroids on histological findings, the usefulness of MRI, positron-emission tomography/CT (PET/CT) and repeated lumbar punctures.
A nomogram prognostic index for risk-stratification in diffuse massive B-cell lymphoma within the rituximab period: a multi-institutional cohort examine
Background: We aimed to ascertain a predictive prognostic risk-stratification mannequin for diffuse massive B-cell lymphoma (DLBCL) within the rituximab period.
Strategies: The info of 1406 main DLBCL sufferers from the Solar Yat-Sen College Most cancers Heart had been analysed to ascertain a nomogram prognostic index (NPI) mannequin for predicting total survival (OS) based mostly on pre-treatment indicators. An unbiased cohort of 954 DLBCL sufferers from three different hospitals was used for exterior validation.
Outcomes: Age, efficiency standing, stage, lactate dehydrogenase, variety of extranodal websites, BCL2, CD5 expression, B signs and absolute lymphocyte and monocyte rely had been the principle components of the NPI mannequin and will stratify the sufferers into 4 distinct classes based mostly on their predicted OS. The calibration curve demonstrated passable settlement between the expected and precise 5-year OS of the sufferers. The concordance index of the NPI mannequin (0.794) was larger than the IPI (0.759) and NCCN-IPI (0.750), and comparable outcomes had been obtained upon exterior validation. For CD5 + DLBCL sufferers, systemic remedy with high-dose methotrexate was related to superior OS in comparison with R-CHOP-based immunochemotherapy alone.
Correlation between circulating blood and microenvironment T lymphocytes in diffuse massive B-cell lymphomas
Goals: Diffuse massive B-cell lymphoma (DLBCL) is characterised by marked scientific and organic heterogeneity, attributable to the tumour cells and their microenvironment.
Strategies: On this examine, we investigated circulating subsets of blood lymphocytes and monocytes and their relationship with T cells within the tumour microenvironment (TME) in chemoresistant and chemosensitive sufferers with DLBCL.
Outcomes: The examine confirmed that (1) absolute lymphocyte rely (ALC) and CD3+ and CD4+ cells had been lowered in chemoresistant sufferers in contrast with chemosensitive sufferers; (2) lymphocyte:monocyte ratio (LMR) confirmed a constructive correlation with peripheral blood CD3+ and CD4+ cells; (3) ALC, LMR, peripheral blood CD3+ and CD4+ cells confirmed a constructive correlation with T cells within the TME.
Conclusions: General, these knowledge recommend that DLBCL with excessive TME T cells show a pre-existing antitumour immune response. Within the rituximab-containing routine, TME T cells are stimulated additional to take part within the immune response in opposition to lymphoma cells. In distinction, DLBCL lymphomas with low T-cell infiltration replicate the absence of a pre-existing antitumour immunity and have a decrease probability of acquiring an optimum response to remedy.
Imprint cytology: Invaluable method to guage recent specimens obtained within the pathology division for Lymphoma workup
On the time of intraoperative session, cytologic preparations together with smears and imprints can be utilized together with frozen sections to extend diagnostic yield; nevertheless, these easy and fast methods will not be adopted by all pathologists and their use varies significantly between establishments. In sufferers underneath investigation for suspected lymphoma, optimum triaging of tissue obtained recent in pathology for lymphoma workup is paramount to maximise the chances of acquiring an correct and clinically significant prognosis and to keep away from the necessity for added procedures and delays in administration, notably within the present context wherein core biopsies have grow to be widespread follow as a primary try to achieve this purpose.
Imprint cytology is invaluable on this regard, additionally as these sufferers might not have a lymphoma however slightly one among its scientific mimics. Herein, imprint cytology is used to strategy recent specimens obtained intraoperatively for lymphoma workup. Extra particularly, how these specimens are triaged for ancillary research, equivalent to circulation cytometry, florescence in situ hybridization, or molecular analyses based mostly on an interpretation of the contact imprints, is described. Detailed imprint cytological findings of typical benign and malignant lymphoid and nonlymphoid lesions are mentioned and illustrated.
 (UbC) (pLenti-GIII-UbC)) DRD5P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723363 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DSTNP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723387 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DSTNP3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723393 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DTX2P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723399 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DURS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723405 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUSPP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723411 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723417 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723423 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723429 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723435 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723441 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723447 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUTP8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723453 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723459 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723465 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L11 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723471 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L14 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723477 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723483 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723489 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L18 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723495 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUX4L19 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723501 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DUXB Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723507 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DVL1L1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723513 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DWS Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723519 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYNLL1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723525 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYRK1AIP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723531 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYRK1AIP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723537 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723543 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723549 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723555 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723561 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT13 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723567 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723573 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723579 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT21 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723585 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYT22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723591 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723597 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723609 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723615 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723621 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723627 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723633 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723639 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723645 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) DYX9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723651 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) E2F3P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723663 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) E2F4P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723669 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) E11S Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723675 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EBM Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723687 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EBR3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723693 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EBR4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723699 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EBVM1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723705 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EBVS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723711 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) ECA1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723717 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) ECEL1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723723 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) ECEL1P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723729 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EDDM3DP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723735 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723741 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEC2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723747 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723753 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723759 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723765 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723771 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723777 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P18 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723783 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723789 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P23 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723795 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P25 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723801 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P26 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723807 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P28 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723813 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P29 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723819 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P30 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723825 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P31 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723831 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P33 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723837 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P34 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723843 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P35 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723849 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P38 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723855 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P40 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723861 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A1P41 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723867 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1A3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723873 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1B2P5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723879 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1DP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723885 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEF1DP4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723891 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EEGV1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723897 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EGI Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723933 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2AP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723951 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2AP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723957 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2AP3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723963 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2AP4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723969 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2S2P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723987 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2S2P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723993 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2S2P6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723999 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF2S2P7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV724005 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF3EP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV724011 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF3FP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV724017 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF3FP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV724023 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EIF4A1P6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV724029 | ABM | 1.0 ug DNA | Ask for price |
